Amber Implants, a Netherlands medtech developing next-generation implants for spinal injuries, named Vincent Gardès as CEO.
Empowering Businesses with Enhanced Security and Usability in Data Backup Solutions MILLSTONE, NJ, UNITED STATES, ...
When a patient with renal cell carcinoma (RCC) progresses on or following the combination of a tyrosine kinase inhibitor (TKI ...
Invesco S&P 500 Equal Weight Utilities ETF offers lower company-specific risk, better value and long-term returns. Read more ...
Clinical Trials Arena on MSN
Akeso’s PD-1/CTLA-4 bispecific trumps chemo in frontline gastric cancer
An independent data monitoring committee has advised Akeso to submit a sNDA to the NMPA for cadonilimab’s approval in gastric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback